SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the introduction of the Infinium HumanHap550-Duo BeadChip, the Company’s fourth multi-sample DNA Analysis solution for genome-wide association (GWA) studies. The HumanHap550-Duo provides the same content as the HumanHap550 BeadChip in a dual-sample format, resulting in significantly greater throughput and lower cost per sample. The introduction of the HumanHap550-Duo is another example of Illumina’s overall strategy to leverage the flexibility of the BeadArray® technology to drive down the per sample cost while providing customers with high quality and product performance.
